Catch up on the top radiology content of the past week.
|Articles|September 1, 1997
ALI posts big increase in third-quarter revenues
ALI posts big increase in third-quarter revenuesALI Technologies continues to gain momentum in the ultrasound miniPACS market, posting a 99% increase in revenues for its third quarter (end-June).For the period, ALI recorded revenues of (U.S.)
Advertisement
ALI posts big increase in third-quarter revenues
ALI Technologies continues to gain momentum in the ultrasound miniPACS market, posting a 99% increase in revenues for its third quarter (end-June).
For the period, ALI recorded revenues of (U.S.) $2.6 million, compared with $1.3 million for the same quarter in 1996. Net income was $398,000, compared with $20,000 in the third quarter of 1996. The Richmond, BC-based vendor also installed 12 more of its UltraPACS ultrasound digital image management systems in the third quarter, bringing its total installed base to 74 as of the end of June.
ALI credits rapid market growth in digital ultrasound image management, as well as increased customer awareness of ALI, for its strong financial results. The company has also benefited from increased opportunities to win lucrative orders to install UltraPACS in multihospital and regional network situations, such as the recent purchase by the Mayo Clinic (PNN 8/97), said Greg Peet, CEO.
While the company does not comment on the specific financial impact of its marketing partners, ALI believes that its OEM alliances are an important factor in its success.
"Specifically, the recent equity stake made by GE Medical Systems has been well received by ALI's existing and prospective clients, because ALI has been strengthened directly from a financial contribution and indirectly by stronger corporate sponsorship," Peet said.
Advertisement
Related to this article
Catch up on key neuroradiology news and research from the past month, including recently published studies involving white matter hyperintensity findings on brain MRI, MRI-enhanced amyloid PET and the newly FDA-approved PET agent floretyrosine F18 for glioma imaging.
Magnetic resonance imaging offered a 29 percent higher sensitivity than CT for differentiating liver metastases, but CT provided 12 percent higher sensitivity than MRI for assessing vascular invasion, according to a new 40-study meta-analysis.
In a recent interview with Diagnostic Imaging, Joseph Cavallo, MD, MBA, offered insights on post-deployment monitoring with AI, the potential for improved workflow efficiency and the ongoing challenge of balancing essential clinical skills and AI literacy in the training of radiology residents and fellows.
Does fractional flow reserve (FFR) or quantitative plaque burden from CCTA provide greater prognostic insight into coronary disease?
In the first of a three-part podcast episode, Wendie Berg, MD, PhD, FACR, FSBI, Manisha Bahl, MD, and Amy Patel, MD share insights on the utility of AI in breast imaging with respect to potential advantages, current concerns and future directions.
Catch up on the most-well viewed radiology content in September 2026.
The BiPASS program, which combines 68Ga PSMA PET imaging with prostate MRI prior to the use of prostate biopsy, is slated to be evaluated in an impending phase 3 trial.
Advertisement
Advertisement
Trending on Diagnostic Imaging
1
Diagnostic Imaging's Weekly Scan: September 27 — October 3
2
The Reading Room Podcast: Current Perspectives, Challenges and Possibilities with AI in Breast Imaging, Part 1
3
Raising Questions on the Prognostic Value of Fractional Flow Reserve from CCTA
4
FDA Grants Fast Track Designation for Pre-Biopsy Use of PSMA PET and MRI for Prostate Cancer Detection
5